Bristol Myers Rockets 12% After AbbVie's Schizophrenia Drug Fails: Bristol Myers Squibb stock rocketed Monday after AbbVie's experimental schizophrenia treatment ...
investors.com/news/technology/bristol-myers-squibb-stock-abbvie-stock-schizophrenia-treatment/
Study flop! AbbVie shares collapse massively - | this pharmaceutical company is the big winner
deraktionaer.de/artikel/pharma-biotech/studienflop-abbvie-aktie-bricht-massiv-ein-diese-pharma-firma-ist-der-grosse-gewinner-20369763.html
AbbVie: Emraclidine's Failure Eliminates An Important Growth Driver: AbbVie's emraclidine setback in phase 2 trials impacts neuroscience pipeline ...
seekingalpha.com/article/4736064-abbvie-emraclidines-failure-eliminates-an-important-growth-driver
Paid articlePaywall
AbbVie shares tumble after schizophrenia drug disappoints : US pharma group says patients who took Emraclidine in clinical trials failed to show a significant ...
ft.com/content/d5179b74-014b-4d5a-b7dc-f3ddd075e720
Paid articlePaywall
AbbVie (ABBV) Stock Falls After New Schizophrenia Drug Fails in Two Trials: AbbVie Inc. shares sank in early trading after two mid-stage trials of its drug to ...
bloomberg.com/news/articles/2024-11-11/abbvie-tumbles-after-new-schizophrenia-drug-fails-in-two-trials
More articles on this subject
Previous
Bristol Myers Rockets 12% After AbbVie's Schizophrenia Drug Fails: Bristol Myers Squibb stock rocketed Monday after AbbVie's experimental schizophrenia treatment ...
investors.com/news/technology/bristol-myers-squibb-stock-abbvie-stock-schizophrenia-treatment/
Study flop! AbbVie shares collapse massively - | this pharmaceutical company is the big winner
deraktionaer.de/artikel/pharma-biotech/studienflop-abbvie-aktie-bricht-massiv-ein-diese-pharma-firma-ist-der-grosse-gewinner-20369763.html
AbbVie's schizophrenia drug misses main goals of two trials: AbbVie said on Monday its experimental schizophrenia drug failed to meet the main goal of two ...
reuters.com/business/healthcare-pharmaceuticals/abbvies-schizophrenia-drug-misses-main-goals-two-trials-2024-11-11/
AbbVie: Emraclidine's Failure Eliminates An Important Growth Driver: AbbVie's emraclidine setback in phase 2 trials impacts neuroscience pipeline ...
seekingalpha.com/article/4736064-abbvie-emraclidines-failure-eliminates-an-important-growth-driver
Paid articlePaywall
AbbVie shares tumble after schizophrenia drug disappoints : US pharma group says patients who took Emraclidine in clinical trials failed to show a significant ...
ft.com/content/d5179b74-014b-4d5a-b7dc-f3ddd075e720
Paid articlePaywall
AbbVie (ABBV) Stock Falls After New Schizophrenia Drug Fails in Two Trials: AbbVie Inc. shares sank in early trading after two mid-stage trials of its drug to ...
bloomberg.com/news/articles/2024-11-11/abbvie-tumbles-after-new-schizophrenia-drug-fails-in-two-trials
Betting Big On AbbVie: A Prescription For Growth And Dividends: AbbVie Inc. is a strong investment opportunity with promising drugs, steady dividends ...
seekingalpha.com/article/4743642-betting-big-on-abbvie-prescription-for-growth-and-dividends
Paid articlePaywall
Blue Bird: Oversold And Undervalued Heading Into 2025: Blue Bird stock underperformed recently but still delivered a 90% return over the past year ...
seekingalpha.com/article/4743900-blue-bird-oversold-and-undervalued-heading-into-2025
Paid articlePaywall
Is The Downshift In U.S. Inflation Stalling?: Disinflation has stalled recently, but economists are debating if this is a temporary blip that will soon give way ...
capitalspectator.com/is-the-downshift-in-us-inflation-stalling/
Paid articlePaywall
Quick Glance: US Rates: 10-Year Bond Aiming for 5%+ by 2025
- The 10-year Treasury yield is expected to end 2024 below neutral but rise to 5-5.5% by 2025.
- Current yields indicate a significant retracement, with the 2-year yield likely stabilizing around 4%.
- Factors such as deficit pressure and Trump’s tax policies will impact long-term rates.
- Market forecasts suggest a favorable outlook for structural fixed-rate payers and short-duration positioning in 2025.
14 Upcoming Dividend Increases: Discover top dividend growth stocks like PHM and LDOS, outperforming ETF benchmarks.
seekingalpha.com/article/4743912-14-upcoming-dividend-increases
Paid articlePaywall
Pioneer Fundamental Growth Fund Q3 2024 Performance And Market Commentary: Pioneer Fundamental Growth Fund portfolio returned 1.93% for the quarter ...
seekingalpha.com/article/4743902-pioneer-fundamental-growth-fund-q3-2024-performance-and-market-commentary
Paid articlePaywall
Grande Group Seeks IPO On Thin Capitalization: Grande Group faces substantial risks in Hong Kong’s financial market. Read why GRAN stock may be a risky IPO with ...
seekingalpha.com/article/4743905-grande-group-seeks-ipo-on-thin-capitalization
Paid articlePaywall
Oversold Intel: Is A Rebound Likely?: Intel faces challenges as CEO exit raises uncertainty. Q4 margins to contract, but cost-saving plans in place for growth.
seekingalpha.com/article/4743081-oversold-intel-is-a-rebound-likely
Paid articlePaywall
The richest man in the world is getting richer: The fortune of Tesla boss Elon Musk has increased to more than 400 billion dollars. According to Bloomberg ...
diepresse.com/19169461/der-reichste-mann-der-welt-wird-immer-reicher
Quick Glance: Elon Musk Ignores Reality of Homelessness
- Elon Musk claimed that the term 'homeless' is often a lie, referring to unhoused individuals as 'violent drug addicts.'
- This statement highlights Musk's lack of understanding of the social issues driving homelessness.
- A HUD report reveals over 650,000 Americans experience homelessness, emphasizing the need for effective housing policies.
- Experts stress that most homeless individuals are not violent but simply in need of shelter.
Northrop Grumman: Double-Digit Free Cash Flow And Why I Am Buying More: Northrop Grumman's free cash flow growth is expected to exceed 15% annually through 2026 ...
seekingalpha.com/article/4743903-northrop-grumman-double-digit-free-cash-flow-and-why-i-am-buying-more
Paid articlePaywall
Candel Therapeutics: Surprising Win Puts Potential Drug Approval In Sight: Candel Therapeutics' CAN-2409 shows a 14.5% improvement in prostate cancer survival ...
seekingalpha.com/article/4743626-candel-therapeutics-surprising-win-puts-potential-drug-approval-in-sight
Paid articlePaywall
Tesla: A Golden Buying Opportunity: Tesla's stock has surged 77% due to strong fundamentals and the upcoming budget Model Q. Click here to find out why I think ...
seekingalpha.com/article/4743491-tesla-tsla-stock-a-golden-buying-opportunity
Paid articlePaywall
Learning From Warren Buffett About Investing In Utilities: The BHE Case Study: Berkshire's (BRK.A) investment in MidAmerican Energy highlights its commitment to ...
seekingalpha.com/article/4742867-learning-from-warren-buffett-about-investing-in-utilities-the-bhe-case-study
Paid articlePaywall
Futu Is A Buy As Dust Has Settled: Futu Holdings is a strong buy due to impressive revenue and net income growth, despite regulatory challenges in mainland China ...
seekingalpha.com/article/4743904-futu-is-a-buy-as-dust-has-settled
Paid articlePaywall
D-Market Elektronik Hizmetler ve Ticaret A.S. 2024 Q3 - Results - Earnings Call Presentation
seekingalpha.com/article/4743296-d-market-elektronik-hizmetler-ve-ticaret-s-2024-q3-results-earnings-call-presentation
Paid articlePaywall
Enovix: Buckle Up, Near-Term Commercialization Will Bring The Company Forward: Enovix boasts a technological edge with its Fab2 facility and key OEM agreements ...
seekingalpha.com/article/4742054-enovix-buckle-up-near-term-commercialization-will-bring-the-company-forward
Paid articlePaywall
Oracle: The Market Has Given Us An Early Christmas Present (Rating Upgrade): Oracle’s growth momentum remains strong despite short-term setbacks ...
seekingalpha.com/article/4743512-oracle-stock-post-earnings-decline-buying-opportunity
Paid articlePaywall
WillScot Holdings: Under The Radar Roll-Up With Attractive Unit Economics: WillScot Holdings is poised to outperform, following the collapse of a pending merger ...
seekingalpha.com/article/4743651-willscot-holdings-under-the-radar-rollup-with-attractive-unit-economics
Paid articlePaywall
Apple's AI Chips Could Shake Up The Market (Rating Upgrade): Apple is reportedly developing its own AI chip with Broadcom, potentially disrupting the AI chip ...
seekingalpha.com/article/4743893-apple-ai-chips-could-shake-up-the-market-rating-upgrade
Paid articlePaywall
Cash COWs And Buried Treasures: 2024 Performance Review: Cash COWs and Buried Treasures portfolios outperform market indices, offering high yields and strong ...
seekingalpha.com/article/4743609-cash-cows-and-buried-treasures-2024-performance-review
Paid articlePaywall
AMD Is Back In The Buy Zone (Rating Upgrade): Advanced Micro Devices, Inc.'s stock has dropped, but potential for growth in AI and Data Center business make it a ...
seekingalpha.com/article/4743571-amd-is-back-in-the-buy-zone-rating-upgrade
Paid articlePaywall
Rocket Lab: Is Neutron A Real Threat To Musk's SpaceX?: SpaceX's Falcon 9 and Starship have strong track records. Read why Rocket Labs' Neutron rocket better ...
seekingalpha.com/article/4743319-rocket-lab-is-neutron-a-real-threat-to-musks-spacex
Paid articlePaywall
Nintendo Now Officially Owns 100% Of Monolith Soft: The chronicle continues
nintendolife.com/news/2024/12/nintendo-now-officially-owns-100percent-of-monolith-soft
IonQ Stock: Still My Preferred Quantum Computing Bet: Investor interest in quantum computing has soared after Google's Willow announcement.
seekingalpha.com/article/4743885-ionq-stock-still-my-preferred-quantum-computing-bet
Paid articlePaywall
MongoDB Q3: Expect AI Workloads To Set Off Platform Consumption Next Year: MongoDB's strong Q3 performance, driven by enterprise growth and strategic initiatives ...
seekingalpha.com/article/4743281-mongodb-q3-expect-ai-workloads-to-set-off-platform-consumption-next-year
Paid articlePaywall
Fresh Insights: Upgrading Nvidia To Buy For Aggressive Growth Opportunities: Nvidia's position in AI and computing, coupled with a $2.4 trillion market potential ...
seekingalpha.com/article/4743293-fresh-insights-upgrading-nvidia-to-buy-for-aggressive-growth-opportunities
Paid articlePaywall
Lockheed Martin: Solid Player With DOGE Concerns: Lockheed Martin's growth in 2024 and diverse revenue base make it a solid long-term investment despite current ...
seekingalpha.com/article/4743277-lockheed-martin-solid-player-with-doge-concerns
Paid articlePaywall
Meta's AI CAPEX Fears, Regulatory Concerns Are Overblown: Meta Platforms’ current roadmap is centered on making glasses the form factor for AI in the coming ...
seekingalpha.com/article/4742865-metas-ai-capex-fears-regulatory-concerns-overblown
Paid articlePaywall
GigaCloud: Buying Opportunity On Its Unjustified Meltdown: GigaCloud Technology investors endured a debilitating bear market, but the worst is likely over ...
seekingalpha.com/article/4742951-gigacloud-buying-opportunity-unjustified-meltdown
Paid articlePaywall
Year-End Review Of High-Yield Closed-End Funds: Explore the world of high-yield CEFs for retirement income, navigating events like distribution cuts and fund ...
seekingalpha.com/article/4742681-year-end-review-of-high-yield-closed-end-funds
Paid articlePaywall
AbbVie's Parkinson's disease drug meets main goal in late-stage study: AbbVie said on Monday its experimental drug to treat Parkinson's disease met the main goal ...
reuters.com/business/healthcare-pharmaceuticals/abbvies-parkinsons-disease-drug-meets-main-goal-late-stage-study-2024-12-09/
SSA Spreads Pushed Wider As Underlying Sovereign Levels Get Reassessed: Sovereign-related and supranational issuers are not just caught up in the reassessment of ...
think.ing.com/articles/ssa-spreads-pushed-wider-as-underlying-sovereign-levels-get-reassessed/
Paid articlePaywall
MoneyHero Limited (MNY) Q3 2024 Earnings Call Transcript: MoneyHero Limited (NASDAQ:MNY) Q3 2024 Earnings Conference Call December 10, 2024 8:00 AM ETCompany ...
seekingalpha.com/article/4743324-moneyhero-limited-mny-q3-2024-earnings-call-transcript
Procore: Future Remains Bright: Procore Technologies, a founder-led company, is disrupting the construction industry with its leading technology platform ...
seekingalpha.com/article/4742606-procore-future-remains-bright
Paid articlePaywall
Allspring Short-Term Bond Plus Fund Q3 2024 Commentary: The Allspring Short-Term Bond Plus Fund outperformed its benchmark Index for the three-month period that ...
seekingalpha.com/article/4743918-allspring-short-term-bond-plus-fund-q3-2024-commentary
Paid articlePaywall
Cracker Barrel: Country Roads, Take Me Home: Cracker Barrel's Five Pillar Plan is driving growth with Q1 2025 comparable sales up 2.9% year-over-year ...
seekingalpha.com/article/4743332-cracker-barrel-stock-country-roads-take-me-home
Paid articlePaywall
Nano Dimension: Governance And Integration Challenges Ahead: Nano Dimension is pursuing inorganic growth through acquisitions of Desktop Metal and Markforged ...
seekingalpha.com/article/4743895-nano-dimension-stock-governance-integration-challenges-ahead
Paid articlePaywall
Super Micro Computer: Recovery Isn't Over Yet: Super Micro Computer stock has surged significantly from its November 2024 lows. Read why I reiterate my buy ...
seekingalpha.com/article/4743794-super-micro-computer-stock-recovery-isnt-over-yet
Paid articlePaywall
Blackstone Secured Lending Fund: Continuing To Deliver A Well Covered Strong Yield
seekingalpha.com/article/4742913-blackstone-secured-lending-fund-continuing-to-deliver-well-covered-strong-yield
Paid articlePaywall
FS KKR Capital: Improved Portfolio Quality, Strong Dividend Coverage: FSK's portfolio quality has improved, offering a 13% dividend yield, despite concerns about ...
seekingalpha.com/article/4743073-fs-kkr-capital-improved-portfolio-quality-strong-dividend-coverage
Paid articlePaywall
PG&E's New Convertible Preferred Offers Dual Benefit: PG&E’s new 6% preferred stock offers a potential 25% upside. See why PCG stock could rise with successful ...
seekingalpha.com/article/4743605-pg-and-e-new-convertible-preferred-offers-dual-benefit
Paid articlePaywall
Chemtrade Logistics: Trading At A 13% Free Cash Flow Yield: Chemtrade Logistics has consistently outperformed market expectations, with strong Q3 revenue and ...
seekingalpha.com/article/4743153-chemtrade-logistics-trading-13-percent-free-cash-flow-yield
Paid articlePaywall
Long-Acting Injectables In schizophrenia Part 3: Patient Treatment Journey: Medscape Live on X (Twitter)
x.com/i/broadcasts/1OyKAZeEOgwGb
Weekly U.K. Gilt Yield And Pound Sterling Simulation, December 6, 2024: 2.1 Basis Points From Inverted Yields
seekingalpha.com/article/4743110-weekly-uk-gilt-yield-and-pound-sterling-simulation-december-6-2024
Paid articlePaywall
Centerspace: Attractively Valued Despite Signs Of Moderating Growth: Centerspace manages 13,014 apartments with a focus on Minnesota, Colorado, and North Dakota ...
seekingalpha.com/article/4743881-centerspace-attractively-valued-despite-signs-of-moderating-growth
Paid articlePaywall
JEPI: Macroeconomic Volatility Could Help Performance In 2025: The JPMorgan Equity Premium Income ETF uses a covered call strategy, which produces income for ...
seekingalpha.com/article/4742870-jepi-macroeconomic-volatility-could-help-performance-in-2025
Paid articlePaywall
Despite Strong Gains, FS KKR's Yield Is Still A Massive 13%: FS KKR Capital offers a dividend yield exceeding 13%, making it attractive for income investors ...
seekingalpha.com/article/4743312-despite-strong-gains-fs-kkrs-yield-massive-13-percent
Paid articlePaywall
Compass Group: Expecting Positive Surprises: Above-expectations FY 2025 financial results could help to bring about a favorable re-rating of Compass Group's ...
seekingalpha.com/article/4743292-compass-group-stock-expecting-positive-earnings-surprises
Paid articlePaywall
Broadcom Q4 Preview: Upgrade Due To Revised VMware Strategy, New Custom AI Chip: Broadcom's AI revenue is expected to grow 10% sequentially, contributing $12 ...
seekingalpha.com/article/4743062-broadcom-q4-preview-upgrade-due-to-revised-vmware-strategy-new-custom-ai-chip
Paid articlePaywall
Walgreens reportedly in talks to be taken private by Sycamore Partners: Walgreens is the country's second-largest non-grocery pharmacy chain.
axios.com/2024/12/10/walgreens-sycamore-take-private
Allspring Small Company Value Fund Q3 2024 Commentary: The Allspring Small Company Value Fund underperformed the benchmark for the third quarter of 2024 ...
seekingalpha.com/article/4743587-allspring-small-company-value-fund-q3-2024-commentary
Paid articlePaywall
Project $1M: End Of A Journey With Mission Accomplished: After 9 years, the Project $1M portfolio has achieved its objective, outperformed S&P 500 by nearly 3% ...
seekingalpha.com/article/4742864-project-1m-end-of-a-journey-with-mission-accomplished
Paid articlePaywall
Silvercorp: Recent Sell-Off Puts The Stock Back Into Buy Territory: Silvercorp's recent 35-40% share price decline is driven by market overreaction to ...
seekingalpha.com/article/4742876-silvercorp-recent-sell-off-puts-the-stock-back-into-buy-territory
Paid articlePaywall
Casey's General Stores, Inc. 2025 Q2 - Results - Earnings Call Presentation: The following slide deck was published by Casey's General Stores, Inc.
seekingalpha.com/article/4743345-caseys-general-stores-inc-2025-q2-results-earnings-call-presentation
Paid articlePaywall
Ellington Credit: Still Waiting For Approval To Transition To A CEF (Rating Downgrade)
seekingalpha.com/article/4743625-ellington-credit-still-waiting-for-approval-to-transition-to-a-cef-rating-downgrade
Paid articlePaywall
Salesforce Is Fairly Valued Now (Rating Downgrade): Salesforce shares surged 11% after beating Q3 top line estimates, driven by strong AI adoption ...
seekingalpha.com/article/4742868-salesforce-is-fairly-valued-now-rating-downgrade
Paid articlePaywall
KULR Technology: Bearish Technicals, But Could Be An Acquisition Target: KULR Technology stock is showing volatility and potential for growth with promising ...
seekingalpha.com/article/4742700-kulr-technology-bearish-technicals-could-be-acquisition-target
Paid articlePaywall
MicroStrategy: Risky Business Model Makes It A Top Short Idea For 2025: Shorting MicroStrategy is a high-conviction idea due to its risky business model of ...
seekingalpha.com/article/4743342-microstrategy-risky-business-model-makes-it-a-top-short-idea-for-2025
Paid articlePaywall
XME: Metals And Mining Stocks Are Cyclically Well Positioned, But Not Cheap: SPDR S&P Metals and Mining ETF seeks to replicate the S&P Metals & Mining Select ...
seekingalpha.com/article/4742861-xme-metals-and-mining-stocks-are-cyclically-well-positioned-but-not-cheap
Paid articlePaywall
CAVA Group: Insiders Deep Six Their Stock At 200x P/E -- You Should, Too: Financial writer warns investors of CAVA Group, Inc.'s overvaluation due to high PE ...
seekingalpha.com/article/4743583-cava-group-insiders-deep-six-their-stock-at-200x-pe-you-should-too
Paid articlePaywall
Stora Enso Looks Promising But Not Yet A Buy For Me: Stora Enso stock shows potential despite declines, but high valuation and profitability concerns make it a ...
seekingalpha.com/article/4743819-stora-enso-looks-promising-but-not-yet-a-buy-for-me
Paid articlePaywall
QDPL: An Alternative To The 4% Rule For Retirement: Discover how Pacer Metaurus US Large Cap Dividend Multiplier 400 ETF offers a 5% dividend yield ...
seekingalpha.com/article/4742914-qdpl-etf-an-alternative-to-4-percent-rule-for-retirement
Paid articlePaywall
Step Aside AI, Google's Quantum Computer Is Here: Google’s Willow chip advances quantum computing with major potential. See why GOOGL stock is a must-own ...
seekingalpha.com/article/4743326-step-aside-ai-google-quantum-computer-is-here
Paid articlePaywall
Columbia Short Term Bond Fund Q3 2024 Commentary: Columbia Short Term Bond Fund’s Institutional Class shares returned 3.19% for the third quarter of 2024 ...
seekingalpha.com/article/4743056-columbia-short-term-bond-fund-q3-2024-commentary
Paid articlePaywall
American Axle: Extremely Undervalued Business Participating In The Electrification Boom
seekingalpha.com/article/4742860-american-axle-extremely-undervalued-business-participating-in-the-electrification-boom
Paid articlePaywall
Bank of America Is A 'Buy' Despite Seeming Overvaluation: Invest in Bank of America Corporation for growth in 2025 despite valuation concerns ...
seekingalpha.com/article/4743639-bank-of-america-a-buy-despite-seeming-overvaluation
Paid articlePaywall
NexGen Energy's Offtake Agreement: A De-Risking Event, A Confirmation Of The Uranium Bull Market
seekingalpha.com/article/4743624-nexgen-energy-offtake-agreement-de-risking-event-confirms-uranium-bull-market
Paid articlePaywall
Super Micro Computer: 3 Reasons The Stock Now Appears Very Buyable: Super Micro Computer's core business remains strong despite recent financial woes ...
seekingalpha.com/article/4742077-super-micro-computer-3-reasons-the-stock-now-appears-very-buyable
Paid articlePaywall
2020 Bulkers: Paid A 16% Dividend Yield In The Past 12 Months: With a fleet of six vessels, 2020 Bulkers is in an excellent position to take advantage of ...
seekingalpha.com/article/4742172-2020-bulkers-paid-a-16-percent-dividend-yield-in-the-past-12-months
Paid articlePaywall
Jobs Prints As Expected, But Geopolitical Risk Escalates; Inflation Lingers: Analysis of current economic trends and risks, including unemployment, inflation ...
seekingalpha.com/article/4742816-jobs-prints-as-expected-geopolitical-risk-escalates-inflation-lingers
Paid articlePaywall
UiPath Inc. (PATH) CFO Ashim Gupta Hosts Barclays 22nd Annual Global Technology Conference (Transcript)
seekingalpha.com/article/4743667-uipath-inc-path-cfo-ashim-gupta-hosts-barclays-22nd-annual-global-technology-conference
Bitcoin Hits $100,000: What Should Intelligent Investors Do?: Bitcoin's universality, scarcity, and decentralization make it an attractive ...
seekingalpha.com/article/4742326-bitcoin-hits-100000-what-should-intelligent-investors-do
Paid articlePaywall
NewLake Capital's Inherent Undervaluation Offers Opportunistic Investors With Rich Returns
seekingalpha.com/article/4742000-newlake-capitals-inherent-undervaluation-offers-opportunistic-investors-with-rich-returns
Paid articlePaywall
SCHD ETF: It Is Boring, And You Can Do Much Better - Is It For You?: Schwab U.S. Dividend Equity ETF is a reliable and stress-free investment option for ...
seekingalpha.com/article/4743097-schd-etf-it-is-boring-and-you-can-do-much-better-is-it-for-you
Paid articlePaywall
Broadcom: This AI Powerhouse Is A Strong Buy: Broadcom's AI revenues, driven by the VMWare acquisition, are expected to significantly increase ...
seekingalpha.com/article/4742334-broadcom-this-ai-powerhouse-is-a-strong-buy
Paid articlePaywall
Morningstar And Others Are Wrong About USMV: Despite underperforming in bull markets, USMV excels in downturns, providing consistent returns ...
seekingalpha.com/article/4742852-morningstar-and-others-are-wrong-about-usmv
Paid articlePaywall
OraSure Technologies: Discounted Assets With An Attractive Free Call Option: OraSure Technologies is an undervalued stock with a strong balance sheet and ...
seekingalpha.com/article/4743648-orasure-technologies-discounted-assets-with-an-attractive-free-call-option
Paid articlePaywall
Starbucks' Gamble: Low Hedge Ratio Amid Surging Green Coffee Prices (Strong Sell)
seekingalpha.com/article/4743016-starbucks-gamble-low-hedge-ratio-amid-surging-green-coffee-prices-strong-sell
Paid articlePaywall
IBM Is In The Midst Of An AI Renaissance - Stop Doubting That: IBM is expected to outperform the S&P 500 in 2024, driven by its GenAI advancements and strong ...
seekingalpha.com/article/4742866-ibm-is-in-the-midst-of-an-ai-renaissance-stop-doubting-that
Paid articlePaywall
Gold Eyes $2,700 As Fed Rate Cut Looms, Geopolitics In Focus: Gold started the week on the offensive. The regime change and geopolitical developments in Syria ...
seekingalpha.com/article/4743322-gold-eyes-2700-fed-rate-cut-looms-geopolitics-in-focus
Paid articlePaywall
Asana: Wait For Growth To Accelerate Before Investing: Asana's 3Q25 earnings showed stabilization and better execution, with improvements in ARR, billings, RPO ...
seekingalpha.com/article/4742677-asana-wait-for-growth-to-accelerate-before-investing
Paid articlePaywall
Pernod Ricard: Very Appealing After A 35% Pullback: We highlight Pernod Ricard's low valuation, strong dividend yield, and growth potential despite recent sales ...
seekingalpha.com/article/4742389-pernod-ricard-very-appealing-after-a-35-percent-pullback
Paid articlePaywall
Next
New to NewsWall?
Sign up now to get your own personalized news!
Trending topics